ATRC Description — AtriCure Inc

AtriCure provides treatments for atrial fibrillation (Afib), left atrial appendage management and post-operative pain. Co.'s ablation and left atrial appendage management products are used by physicians during both open-heart and minimally invasive procedures. Co.'s Isolator® Synergy™ Ablation System is approved by U.S. Food and Drug Administration (FDA) for the treatment of persistent and long-standing persistent Afib concomitant to other open-heart surgical procedures. The EPi-Sense® system is approved by FDA to treat patients with long-standing persistent Afib. All of Co.'s other ablation devices are cleared for sale in U.S., including its other radio frequency and cryoablation products.

Company Name: 
AtriCure Inc
Medical Instruments & Supplies
Number of ETFs Holding ATRC: 
Total Market Value Held by ETFs: 
Total Market Capitalization: 
% of Market Cap. Held by ETFs: 
 ETF   ATRC Weight   ATRC Amount 
 VTI   0.01%   $64,193,692         
 VB   0.05%   $53,582,012         
 IWM   0.09%   $46,215,532         
 VBK   0.11%   $30,722,839         
 VXF   0.04%   $30,267,027         
 IHI   0.19%   $11,366,692         
 IWO   0.11%   $10,696,002         
 XHE   1.75%   $9,431,818         
 IWN   0.07%   $7,407,762         
 VHT   0.04%   $7,132,165         
List of all 31 ETFs holding ATRC »
Quotes delayed 20 minutes

Email EnvelopeFree ATRC Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts

Strong Buy (3.57 out of 4)
60th percentile
(ranked higher than approx. 60% of all stocks covered)

Analysts Forecast:
ATRC Price Target

Based on data provided by Zacks Investment Research via

ETFs Holding ATRC | AtriCure Inc | ETF Channel |

Copyright © 2010 - 2023, All Rights Reserved Nothing in ETF Channel is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and ETF videos powered by Market News Video. Quote data delayed at least 20 minutes; data powered by Ticker Technologies, and Mergent. Contact ETF Channel; Meet Our Editorial Staff.